WVE Adrian Rawcliffe sells $109K worth of shares
Nov 15, 2025, 5:37 AM
0.00%
What does WVE do
Wave Life Sciences is a clinical-stage biotechnology company focused on RNA medicines, utilizing its PRISM platform to develop treatments for disorders like Duchenne muscular dystrophy and Huntington’s disease. Founded in 2015, it employs 266 people and is advancing RNA-targeting modalities such as editing and interference.
Adrian Rawcliffe sold 16,115 shares of WVE on 13 November at $6.79 per share, worth a total of $109K. They now own 12,700 WVE shares, or a 56% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.